Vaccination against meningitis B: is it worth it?

Peter English

Article Type

Case Report

Published

When a new vaccine is licensed having passed the tests for efficacy and safety, governments who have to pay for it to be used, as in the UK, will carry out a careful economic appraisal before making it generally available. In this challenging article, Dr Peter English discusses whether or not a new vaccine for meningitis that has just been licensed and that could save lives is actually worth it.

Read more

Is ‘GOLD’ standard for the management of COPD in clinical practice?

Barbara P Yawn

Article Type

Case Report

Published

Primary therapy for chronic obstructive pulmonary disease (COPD) is the removal of the toxic agent (in most cases, tobacco smoke). Additional therapy includes bronchodilators. Inhaled corticosteroids and long-acting bronchodilators can be used to prevent and reduce the risk of exacerbations. COPD is a systemic disease and often requires therapy of its protean-associated morbidities from depression to osteoporosis and muscle wasting. Despite pessimism from some, COPD is treatable.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.